| Original language | English |
|---|---|
| Pages (from-to) | 971-976 |
| Number of pages | 6 |
| Journal | Canadian Journal of Cardiology |
| Volume | 36 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - Jul 2020 |
ASJC Scopus Subject Areas
- Cardiology and Cardiovascular Medicine
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Canadian Journal of Cardiology, Vol. 36, No. 7, 07.2020, p. 971-976.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Safe Reintroduction of Cardiovascular Services During the COVID-19 Pandemic
T2 - From the North American Society Leadership
AU - Wood, David A.
AU - Mahmud, Ehtisham
AU - Thourani, Vinod H.
AU - Sathananthan, Janarthanan
AU - Virani, Alice
AU - Poppas, Athena
AU - Harrington, Robert A.
AU - Dearani, Joseph A.
AU - Swaminathan, Madhav
AU - Russo, Andrea M.
AU - Blankstein, Ron
AU - Dorbala, Sharmila
AU - Carr, James
AU - Virani, Sean
AU - Gin, Kenneth
AU - Packard, Alan
AU - Dilsizian, Vasken
AU - Légaré, Jean François
AU - Leipsic, Jonathon
AU - Webb, John G.
AU - Krahn, Andrew D.
N1 - Funding Information: Dr. Wood has received unrestricted grant support from Edwards Lifesciences and Abbott Vascular; and has served as a consultant to Edwards Lifesciences, Medtronic, Abbott Vascular, and Boston Scientific. Dr. Mahmud has served as a consultant for Abiomed, Medtronic, and Boston Scientific; has received clinical trial support from Corindus; has served as Chairman of the Data Safety Monitoring Board for CAD III and CAD IV studies sponsored by Shockwave, Inc.; and has served as Chairman of the Data Safety Monitoring Board for the EluNIR-HBR Study sponsored by Medinol. Dr. Thourani has served as an advisor for and/or received research support from Edwards Lifesciences, Abbott Vascular, Gore Vascular, Boston Scientific, and JenaValve. Dr Sathananthan has served as a consultant for Edwards Lifesciences and Medtronic. Dr. Harrington has served on an Advisory Committee for Element Science. Dr. Russo has received grant support from Boston Scientific and Medilynx; and has served as a steering committee member (without honoraria) for Boston Scientific and Apple. Dr. Dorbala has served as an advisor and has received institutional research support from Pfizer and GE Healthcare. Dr. Carr has received research funding from Siemens, Bayer, and Guerbet; and has served as a consultant for Siemens and Bayer. Dr. Virani has served as an advisor to Medtronic; and has served as a consultant to Abbott Vascular. Dr. Leipsic has served as a consultant to and has stock options in HeartFlow and Circle CVI; has received research support from GE Healthcare and Edwards Lifesciences; has CT core laboratory research agreements with Edwards, Abbott, Medtronic, and NEOVASC, for which he takes no compensation; and has served on the Speakers Bureau of GE Healthcare and Philips. Dr. Webb has served as a consultant to Edwards Lifesciences, Abbott, and Boston Scientific. Dr. Krahn has served as a consultant for Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: Dr. Wood has received unrestricted grant support from Edwards Lifesciences and Abbott Vascular; and has served as a consultant to Edwards Lifesciences, Medtronic, Abbott Vascular, and Boston Scientific. Dr. Mahmud has served as a consultant for Abiomed, Medtronic, and Boston Scientific; has received clinical trial support from Corindus; has served as Chairman of the Data Safety Monitoring Board for CAD III and CAD IV studies sponsored by Shockwave, Inc.; and has served as Chairman of the Data Safety Monitoring Board for the EluNIR-HBR Study sponsored by Medinol. Dr. Thourani has served as an advisor for and/or received research support from Edwards Lifesciences, Abbott Vascular, Gore Vascular, Boston Scientific, and JenaValve. Dr Sathananthan has served as a consultant for Edwards Lifesciences and Medtronic. Dr. Harrington has served on an Advisory Committee for Element Science. Dr. Russo has received grant support from Boston Scientific and Medilynx; and has served as a steering committee member (without honoraria) for Boston Scientific and Apple. Dr. Dorbala has served as an advisor and has received institutional research support from Pfizer and GE Healthcare. Dr. Carr has received research funding from Siemens, Bayer, and Guerbet; and has served as a consultant for Siemens and Bayer. Dr. Virani has served as an advisor to Medtronic; and has served as a consultant to Abbott Vascular. Dr. Leipsic has served as a consultant to and has stock options in HeartFlow and Circle CVI; has received research support from GE Healthcare and Edwards Lifesciences; has CT core laboratory research agreements with Edwards, Abbott, Medtronic, and NEOVASC, for which he takes no compensation; and has served on the Speakers Bureau of GE Healthcare and Philips. Dr. Webb has served as a consultant to Edwards Lifesciences, Abbott, and Boston Scientific. Dr. Krahn has served as a consultant for Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
PY - 2020/7
Y1 - 2020/7
UR - http://www.scopus.com/inward/record.url?scp=85087378783&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087378783&partnerID=8YFLogxK
U2 - 10.1016/j.cjca.2020.04.031
DO - 10.1016/j.cjca.2020.04.031
M3 - Article
C2 - 32380228
AN - SCOPUS:85087378783
SN - 0828-282X
VL - 36
SP - 971
EP - 976
JO - Canadian Journal of Cardiology
JF - Canadian Journal of Cardiology
IS - 7
ER -